InVitro International Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Net Income	0.11	0	0.02	0.1	0.05
Depreciation & Amortization	0	0	0	0	0
Other Amortization	0	0	0	0	0
Loss (Gain) From Sale of Investments	-	-	0.09	-0.01	-0.01
Stock-Based Compensation	0.01	0.01	0.01	0.01	0.03
Other Operating Activities	-	-	-0.1	-0.11	-
Change in Accounts Receivable	0.04	-0.05	0.07	0.02	-0.05
Change in Inventory	-0.02	-0.01	-0.02	0.03	-0.01
Change in Accounts Payable	-0.01	0	0	-0.01	-0.01
Change in Income Taxes	-	-	-0.01	-0	0
Change in Other Net Operating Assets	-0.03	-0.03	-0.03	0	-0.03
Operating Cash Flow	0.1	-0.06	0.04	0.03	-0.02
Operating Cash Flow Growth	-	-	27.00%	-	-
Capital Expenditures	-	-0	-0.01	-0	-
Investment in Securities	-0.04	-0.82	0.69	0.02	-0.04
Investing Cash Flow	-0.04	-0.82	0.69	0.01	-0.04
Short-Term Debt Issued	-	-	-	0.1	0.11
Total Debt Issued	-	-	-	0.1	0.11
Net Debt Issued (Repaid)	-	-	-	0.1	0.11
Repurchase of Common Stock	-	-	-0.01	-	-
Financing Cash Flow	-	-	-0.01	0.1	0.11
Foreign Exchange Rate Adjustments	-	-	-	-0	0
Net Cash Flow	0.06	-0.88	0.71	0.14	0.05
Free Cash Flow	0.1	-0.06	0.03	0.03	-0.02
Free Cash Flow Growth	-	-	8.16%	-	-
Free Cash Flow Margin	12.15%	-7.56%	3.66%	2.88%	-2.02%
Free Cash Flow Per Share	0.00	-0.00	0.00	0.00	-0.00
Cash Income Tax Paid	-	0	-	0.01	0.01
Levered Free Cash Flow	0.06	-0.08	-0.05	0.04	-0.05
Unlevered Free Cash Flow	0.06	-0.08	-0.05	0.04	-0.05
Change in Working Capital	-0.02	-0.08	0.02	0.04	-0.1